These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 16505657

  • 1. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N, Malcangi V, Dalfino L, Trerotoli P, Guagliardi C, Bortone D, Faconda G, Ribezzi M, Ancona G, Bruno F, Fiore T.
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [Abstract] [Full Text] [Related]

  • 2. Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
    Samuels J, Finkel K, Gubert M, Johnson T, Shaw A.
    Ren Fail; 2005 Mar; 27(1):101-5. PubMed ID: 15717642
    [Abstract] [Full Text] [Related]

  • 3. Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review.
    Moffett BS, Mott AR, Nelson DP, Goldstein SL, Jefferies JL.
    Pediatr Crit Care Med; 2008 Jul; 9(4):403-6. PubMed ID: 18496409
    [Abstract] [Full Text] [Related]

  • 4. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery.
    Roasio A, Lobreglio R, Santin A, Landoni G, Verdecchia C.
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):23-6. PubMed ID: 18249326
    [Abstract] [Full Text] [Related]

  • 5. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine?
    Duke GJ, Briedis JH, Weaver RA.
    Crit Care Med; 1994 Dec; 22(12):1919-25. PubMed ID: 7988127
    [Abstract] [Full Text] [Related]

  • 6. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
    Barr LF, Kolodner K.
    Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903
    [Abstract] [Full Text] [Related]

  • 7. Fenoldopam: renal-dose dopamine redux?
    Murray PT.
    Crit Care Med; 2006 Mar; 34(3):910-1. PubMed ID: 16505681
    [No Abstract] [Full Text] [Related]

  • 8. Fenoldopam in critically ill patients with early renal dysfunction. A crossover study.
    Cobas M, Paparcuri G, De La Pena M, Cudemus G, Barquist E, Varon A.
    Cardiovasc Ther; 2011 Aug; 29(4):280-4. PubMed ID: 20955210
    [Abstract] [Full Text] [Related]

  • 9. Dopamine "renal dose" versus fenoldopam mesylate to prevent ischemia-reperfusion injury in renal transplantation.
    Fontana I, Germi MR, Beatini M, Fontana S, Bertocchi M, Porcile E, Saltalamacchia L, Ornis S, Ghinolfi D, Bonifazio L, Valente U.
    Transplant Proc; 2005 Aug; 37(6):2474-5. PubMed ID: 16182714
    [Abstract] [Full Text] [Related]

  • 10. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial.
    Bove T, Landoni G, Calabrò MG, Aletti G, Marino G, Cerchierini E, Crescenzi G, Zangrillo A.
    Circulation; 2005 Jun 21; 111(24):3230-5. PubMed ID: 15967861
    [Abstract] [Full Text] [Related]

  • 11. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
    Ranucci M, Soro G, Barzaghi N, Locatelli A, Giordano G, Vavassori A, Manzato A, Melchiorri C, Bove T, Juliano G, Uslenghi MF.
    Ann Thorac Surg; 2004 Oct 21; 78(4):1332-7; discussion 1337-8. PubMed ID: 15464494
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction.
    Garwood S, Swamidoss CP, Davis EA, Samson L, Hines RL.
    J Cardiothorac Vasc Anesth; 2003 Feb 21; 17(1):17-21. PubMed ID: 12635055
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL.
    Crit Care Med; 2006 Sep 21; 34(9):2310-6. PubMed ID: 16878035
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
    Stone GW, Tumlin JA, Madyoon H, Lepor NE, McCullough PA, Mathur VS, Murray PT, O'Neill WW.
    Rev Cardiovasc Med; 2001 Sep 21; 2 Suppl 1():S31-6. PubMed ID: 12439366
    [Abstract] [Full Text] [Related]

  • 19. Fenoldopam vs dopamine as a nephroprotective strategy during living donor kidney transplantation: preliminary data.
    Sorbello M, Morello G, Paratore A, Cutuli M, Mistretta G, Belluoccio AA, Veroux M, Veroux P, Macarone M, Gagliano M, Mangianeli S.
    Transplant Proc; 2007 Sep 21; 39(6):1794-6. PubMed ID: 17692615
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?
    Priglinger U, Delle Karth G, Geppert A, Joukhadar C, Graf S, Berger R, Hülsmann M, Spitzauer S, Pabinger I, Heinz G.
    Crit Care Med; 2003 May 21; 31(5):1405-9. PubMed ID: 12771610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.